Treatment of Steroid Dependent Idiopathic Nephrotic Syndrome in Children With Low Doses of Interleukin 2: a Pilot Study
Condition(s):Nephrotic Syndrome Steroid-Dependent; Interleukin 2Last Updated:May 30, 2018Withdrawn
Hide Studies Not Open or Pending
Condition(s):Nephrotic Syndrome Steroid-Dependent; Interleukin 2Last Updated:May 30, 2018Withdrawn
Condition(s):Idiopathic Nephrotic SyndromeLast Updated:May 2, 2011Unknown status
Condition(s):Nephrotic SyndromeLast Updated:July 6, 2017Completed
Condition(s):Childhood Idiopathic Nephrotic SyndromeLast Updated:March 23, 2015Completed
Condition(s):Nephrotic SyndromeLast Updated:October 31, 2023Recruiting
Condition(s):Nephrotic Syndrome; Sodium-Glucose Transporter 2 InhibitorsLast Updated:September 7, 2023Completed
Condition(s):Nephrotic Syndrome Steroid-ResistantLast Updated:August 2, 2017Unknown status
Condition(s):Nephrotic Syndrome, Minimal ChangeLast Updated:January 12, 2016Unknown status
Condition(s):Nephrotic Syndrome in ChildrenLast Updated:October 12, 2023Recruiting
Condition(s):Nephrotic Syndrome; ProteinuriaLast Updated:July 24, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.